Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, SCZ

Centre of Excellence at Perley Rideau studies technology to decontaminate and sanitize medical face masks


Home-grown protection against COVID-19 for long-term care residents, staff and first responders

OTTAWA, April 29, 2020 /CNW/ - Ottawa's Perley and Rideau Veterans' Health Centre has announced a major research study to test revolutionary new Canadian technology to decontaminate and sanitize medical face masks. Sold under the trade name Cl?an Flow Health Care Mini, the technology has been licensed for the reprocessing of N95 respirators but has not yet been validated for use with the type of procedural masks more widely used in long-term care homes, hospitals and other venues for protection against the COVID-19 virus and other communicable diseases.

"The Ontario government challenged us to find innovative ways to address the COVID-19 pandemic. We think we have found one," says Perley Rideau CEO Akos Hoffer. "The Cl?an Flow Health Care Minitm promises to help us address the critical shortage of personal protective equipment at the same time as we find lasting, cost-effective, home-grown solutions to protect and promote the health and safety of our residents, long-term care staff, first responders, hospital and other essential workers."

"In times like these, it is wonderful to see not-for-profit long-term care providers taking bold steps to find solutions to benefit the broader sector," says Lisa Levin, CEO, AdvantAge Ontario. "The Perley Rideau is demonstrating incredible leadership in joining forces with Ontario-based Cl?an Works to trial their innovative Cl?an Flow Health Care Mini to sanitize N95 and procedural masks. The brave men and women on the frontlines of health care who are tirelessly battling COVID-19 deserve to know that personal protective equipment is there when they need it. We applaud the Perley Rideau for this valuable contribution to that effort."

In addition to validating the technology's three-step waterless process with procedural masks, the Centre of Excellence at Perley Rideau has issued a call for collaboration to researchers in government and elsewhere to establish reprocessing protocols for all types of personal protective equipment (PPE). Already, a research collaboration focusing on N95 respirators has been agreed with CHEO.

Quick Facts:

Multimedia:

B-Roll: Medical mask decontamination underway at Perley Rideau Centre of Excellence in Frailty-Informed Care https://bit.ly/3aMcX8R 
Photos: https://bit.ly/2yQC8Ks 

About Us

The Perley and Rideau Veterans' Health Centre is one of the largest and most progressive long-term care homes in Ontario. In addition to the 450 long-term and short-stay care beds for Veterans and members of the public, the Perley Rideau campus includes a Seniors Village with independent-living apartments for 200 seniors. It employs a staff of more than 850.

Created in 2019, the Perley Rideau Centre of Excellence in Frailty-Informed Care is leading the way in elder care in Canada with developments such as the SeeMetm: Understanding frailty together assessment and treatment program and the ground-breaking hospital-to-home Sub-Acute Care Unit for Frail Elderly (SAFE Unit).

 

SOURCE Centre of Excellence in Frailty-Informed Care


These press releases may also interest you

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...



News published on and distributed by: